서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 29 of 29

Issue DateTitle / Author(s) / CitationFileAltmetrics
2008-12
Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients
DOI
2009-05
Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation

Lee, Jeong-Ok; Kim, Dae-Young; Lim, Joo Han; Seo, Myung-Deok; Yi, Hyeon Gyu; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Journal of Gastroenterology and Hepatology, Vol.24 No.5, pp.800-805

DOI
2011-04
Clinical Outcomes of Sorafenib Treatment in Patients With Metastatic Hepatocellular Carcinoma Who Had Been Previously Treated With Fluoropyrimidine Plus Platinum-based Chemotherapy

Kim, Ji-Won; Lee, Jeong-Ok; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

American Journal of Clinical Oncology, Vol.34 No.2, pp.125-129

DOI
2011-09
Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer
DOI
2013-09
How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
view fileDOI
2014-08
Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer

Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog

International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600

DOI
2014-10
Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
view fileDOI
2016-01
Gefitinib-induced interstitial lung disease in korean lung cancer patients
view fileDOI
2016-03
Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease
DOI
2016-07
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
DOI
2017-01
Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications
DOI
2017-01
Different predictive values of interim F-18-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma

Kim, Jihyun; Lee, Jeong-Ok; Paik, Jin Ho; Lee, Won Woo; Kim, Sang Eun; Song, Yoo Sung

Annals of Nuclear Medicine, Vol.31 No.1, pp.1-11

DOI
2017-06
Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
DOI
2017-09
EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
DOI
2017-11
Diagnosis of secondary peripheral neurolymphomatosis: A multi-center experience
DOI
2018-02
Early therapeutic drug monitoring of posaconazole oral suspension in patients with hematologic malignancies
DOI
2018-07
The genetic polymorphism UGT1A4*3 is associated with low posaconazole plasma concentrations in hematological malignancy patients receiving the oral suspension
DOI
2018-11
Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma

Kwon, Hyun Jung; Yang, Jeong Mi; Lee, Jeong-Ok; Lee, Jong Seok; Paik, Jin Ho

Journal of Translational Medicine, Vol.16 No.1, p. 320

DOI
2019-04
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
DOI
2019-04
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
view fileDOI
2019-10
Body Cavity- Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma
DOI
2021-08
A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas
2021-11
Clinicopathologic and Prognostic Significance of Bruton's Tyrosine Kinase Expression in Diffuse Large B-Cell Lymphoma

Han, Yeon Bi; Yang, Jeong Mi; Kwon, Hyun Jung; Lee, Jeong-Ok; Lee, Jong Seok; Paik, Jin Ho

Anticancer Research, Vol.41 No.11, pp.5677-5692

DOI
2021-12
R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
DOI
2022-01
Bcl-6-dependent risk stratification by nuclear expression of Peli1 in diffuse large B-cell lymphoma

Lee, Ki Rim; Lee, Jeong-Ok; Lee, Jong Seok; Paik, Jin Ho

Journal of Cancer, Vol.13 No.14, pp.3615-3622

DOI
2022-01
Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study
DOI
2022-01
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma

Lee, Ki Rim; Koh, Jiwon; Jeon, Yoon Kyung; Kwon, Hyun Jung; Lee, Jeong-Ok; Paik, Jin Ho

Journal of Pathology and Translational Medicine, Vol.56 No.1, pp.32-39

DOI
2022-11
Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with RUNX1 ::RUNX1T1
DOI
2023-01
Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression
DOI
1